id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2006-N-0238-0027,FDA,FDA-2006-N-0238,"OMB Review [12866], Expanded Access to INDs,  Final Rule Published 8/13/09",Other,References (internal) (REF),2009-08-24T04:00:00Z,2009,8,2009-08-24T04:00:00Z,,2025-04-11T22:14:10Z,,0,0,0900006480a0c8f0
FDA-2006-N-0238-0026,FDA,FDA-2006-N-0238,Expanded Access to Investigational Drugs for Treatment Use,Rule,NFR-Notice of Final Rule,2009-08-13T04:00:00Z,2009,8,2009-08-13T04:00:00Z,,2015-06-02T18:01:51Z,E9-19005,0,0,0900006480a084e7